Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma

Journal article

Peer reviewed

H. Mahdi, P.G. Rose, M. Elshaikh, A.R. Munkarah, D. Isrow, S. Singh, S.E. Waggoner, R. Ali-Fehmi, J. Harding, R.T. Morris, …

Gynecologic oncology, Vol.137, pp.163-163

01/04/2015

Metrics

1 Record Views

Title: Adjuvant vaginal brachytherapy decreases the risk of vaginal recurrence in patients with stage I non-invasive uterine papillary serous carcinoma
Creators - without role: H. Mahdi - Cleveland Clinic
P.G. Rose - Cleveland Clinic
M. Elshaikh - Henry Ford Health System
A.R. Munkarah - Henry Ford Health System
D. Isrow - Henry Ford Health System
S. Singh - University Hospitals Case Medical Center
S.E. Waggoner - University Hospitals Case Medical Center
R. Ali-Fehmi - Wayne State University
J. Harding - Case Western Reserve University
R.T. Morris - Wayne State University
R. DeBernardo - Cleveland Clinic
Publication Details: Gynecologic oncology, Vol.137, pp.163-163
Publisher: Elsevier Inc
Identifiers: 9929285808331
Academic Unit: Shaqra University
Language: English
Resource Type: Journal article